Allarity Therapeutics (ALLR) Intangibles (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Intangibles came in at $9.6 million in Q2 2024, down 1.62% YoY from $9.7 million in Q3 2023, and down 1.03% on a QoQ basis from $9.7 million in Q1 2024.
Allarity Therapeutics (ALLR) Intangibles (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Intangibles data on file, last reported at $9.6 million in Q2 2024.
- Quarterly Intangibles fell 1.62% year-over-year to $9.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $9.6 million (down 1.62% YoY) and the FY2023 annual result came in at $9.9 million, up 3.37% from the prior year.
- Intangibles eased to $9.6 million in Q2 2024, from $9.7 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $39.0 million in Q3 2021 to a low of $9.5 million in Q3 2023.
- A 5-year average of $15.7 million and a median of $9.9 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles tumbled 69.14% — and 2023, when it increased 3.37%.
- Tracing ALLR's Intangibles over 5 years: stood at $30.5 million in 2020, then fell by 7.73% to $28.1 million in 2021, then tumbled by 66.06% to $9.5 million in 2022, then climbed by 3.37% to $9.9 million in 2023, then declined by 3.18% to $9.6 million in 2024.
- The last three Intangibles figures came in at $9.6 million (Q2 2024), $9.7 million (Q1 2024), and $9.9 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 9.87 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 9.71 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 12.03 Mn |
| Jun 30, 2022 | 12.81 Mn |
| Mar 31, 2022 | 13.69 Mn |
| Dec 31, 2021 | 28.14 Mn |
| Sep 30, 2021 | 38.98 Mn |
| Dec 31, 2020 | 30.49 Mn |